Prophylactic and therapeutic benefits of short-term 9-[2-(R)- (phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA

Journal of Virology

Volumn 74, Issue 4, 2000, Pages 1767-1774

  Van Rompay, Koen K A ^a   Miller, Michael D ^d   Marthas, Marta L ^a   Margot, Nicolas A ^d   Dailey, Peter J ^c   Canfield, Don R ^a   Tarara, Ross P ^a   Cherrington, Julie M ^d   Aguirre, Nancy L ^a   Bischofberger, Norbert ^d   Pedersen, Niels C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYER CORPORATION   (United States)

^d GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE ANTIGEN; TENOFOVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE COURSE; DRUG SENSITIVITY; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INOCULATION; MACACA; NEWBORN; NONHUMAN; PERINATAL INFECTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIREMIA;

ADENINE; ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTIVIRAL AGENTS; MACACA MULATTA; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; RESEARCH DESIGN; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033947591     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.4.1767-1774.2000     Document Type: Article

References (50)

1. Angarana, G., L. Monno, A. Appice, A. Giannelli, C. Romalli, C. Fico, and G. Pastore. 1994. Transmission of zidovudine-resistant HIV-1 through heterosexual contacts. AIDS 8:1013-1014.
2. Baba, T. W., J. Koch, E. S. Mittler, M. Greene, M. Wyand, D. Penninck, and R. M. Ruprecht. 1194. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res. Hum. Retroviruses 10:351-357.
3. Cao, Y., P. Krogstadt, B. T. Korber, R. A. Koup, M. Muldoon, C. Macken, J.-L. Song, Z. Jin, J.-Q. Zhao, S. Clapp, I. C. Y. Chen, D. D. Ho, A. J. Ammann, and the Ariel Project Investigators. 1997. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat. Med. 3:549-552.
4. Colgrove, R. C., J. Pitt, P. H. Chung, S. L. Welles, and A. J. Japour. 1998. Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 12:2281-2288.
5. Conlon, C. P., P. Klenerman, A. Edwards, B. A. Larder, and R. E. Phillips. 1994. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance. J. Infect. Dis. 169:411-415.
6. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, R. L. R. L. Jacobson, E. Jiminez, E. O'Neill, B. Bazin, J.-F. Delfraissy, M. Culnane, R. Coombs, M. Elkins, J. Moye, P. Stratton, and J. Balsley for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1173-1180.
7. Conway, B., V. Montessori, D. Rouleau, J. S. G. Montaner, M. V. O'Shaughnessy, S. Fransen, A. Shillington, D. Weislow, and D. L. Mayers. 1999. Primary lamivudine resistance in acute/early human immunodeficiency virus infection. Clin. Infect. Dis. 28:910-911.
8. Dawson-Saunders, B., and R. G. Trapp. 1990. Basic and clinical biostatistics. Appleton & Lange, Norwalk, Conn.
9. Deeks, S. G., P. Barditch-Crovo, P. S. Lietman, F. Hwang, K. C. Cundy, J. F. Rooney, N. S. Hellmann, S. Safrin, and J. Kahn. 1998. Safety, pharmacokinetics and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults. Antimicrob. Agents Chemother. 42:2380-2384.
10. Eastman, P. S., D. E. Shapiro, R. W. Coombs, L. M. Frenkel, G. D. McSherry, P. Britto, S. A. Herman, and R. S. Sperling. 1998. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J. Infect. Dis. 177:557-564.
11. Erice, A., D. L. Mayers, D. G. Strike, K. J. Sannerud, F. E. McCutchan, K. Henry, and H. H. Balfour. 1993. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N. Engl. J. Med. 328: 1163-1165.
12. European Collaborative Study. 1997. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 13:1377-1385.
13. Fitzgibbon, J. E., S. Gaur, L. D. Frenkel, F. Laraque, B. R. Edlin, and D. T. Dubin. 1993. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N. Engl. J. Med. 329:1835-1841.
14. Frenkel, L. M., L. E. I. Wagner, L. M. Demeter, S. Dewhurst, R. W. Coombs, B. L. Murante, and R. C. Reichman. 1995. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus. Clin. Infect. Dis. 20:1321-1326.
15. Goudsmit, J., A. De Ronde, D. D. Ho, and A. S. Perelson. 1996. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70:5662-5664.
16. Guay, L. A., P. Musoke, T. Fleming, D. Bagenda, M. Allen, C. Nakabiito, J. Sherman, P. Bakaki, C. Ducar, M. Deseyve, L. Emel, M. Mirochnick, M. G. Fowler, L. Mofenson, P. Miotti, K. Dransfield, D. Bray, F. Mmiro, and J. B. Jackson. 1999. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 354:795-802.
17. Hecht, F. M., R. M. Grant, C. J. Petropoulos, B. Dillon, M. A. Chesney, H. Tian, N. S. Hellmann, N. I. Bandrapalli, L. Digilio, B. Branson, and J. O. Kahn. 1998. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N. Engl. J. Med. 339:307-311.
18. Hirsch, M. S., B. Conway, R. T. D'Aquila, V. A. Johnson, F. Brun-Vézinet, B. Clotet, L. M. Demeter, S. M. Hammer, D. M. Jacobsen, D. R. Kuritzkes, C. Loveday, J. W. Mellors, S. Vella, and D. D. Richman for the International AIDS Society - USA panel. 1998. Antiretroviral drug resistance testing in adults with HIV infection. Implications for clinical management. JAMA 279:1984-1991.
19. Imrie, A., A. Beveridge, W. Genn, J. Vizzard, and D. A. Cooper. 1997. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. J. Infect. Dis. 175:1502-1506.
20. Imrie, A., A. Carr, C. Duncombe, R. Finalyson, J. Vizzard, M. Law, J. Kaldor, R. Penny, and D. Cooper. 1996. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sidney Primary HIV Infection Study Group. J. Infect. Dis. 174:195-198.
21. Kahn, J., and B. Walker. 1998. Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med. 339:33-39.
22. Kully, C., S. Yerly, P. Erb, C. Kind, A. Krautheim, L. Perrin, and C. Rudin. 1999. Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study. J. Infect. Dis. 179:705-708.
23. Lafeuillade, A., C. Poggi, C. Tamalet, N. Profizi, C. Tourres, and O. Costes. 1997. Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 175: 1051-1055.
24. Lohman, B. L., J. Higgins, M. L. Marthas, P. A. Marx, and N. C. Pedersen. 1991. Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29:2187-2192.
25. Lü, X., H. Kiyono, D. Lu, S. Kawabata, J. Torten, S. Srinivasan, P. J. Dailey, J. R. McGhee, T. Lehner, and C. J. Miller. 1998. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. AIDS 12:1-10.
26. Marthas, M. L., K. K. A. Van Rompay, M. Otsyula, C. J. Miller, D. Canfield, N. C. Pedersen, and M. B. McChesney. 1995. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J. Virol. 69:4198-4205.
27. Mayaux, M. J., E. Dussaix, J. Isopet, C. Rekacewicz, L. Mandelbrot, N. Ciraru-Vigneron, M. C. Allemon, V. Chambrin, C. Katlama, J. F. Delfraissy, J. Puel, for the SEROGEST Cohort Group. 1997. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French Perinatal Cohort Studies. J. Infect. Dis. 175:172-175.
28. Melvin, A. J., S. K. Burchett, D. H. Watts, J. Hitti, J. P. Hughes, C. L. McLellan, P. D. King, E. J. Johnson, B. L. Williams, L. M. Frenkel, and R. W. Coombs. 1997. Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:232-236.
29. Miller, C. J., M. Marthas, J. Torten, N. J. Alexander, J. P. Moore, G. F. Doncel, and A. G. Hendrickx. 1994. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:6391-6400.
30. Myers, G., J. A. Berzofsky, B. Korber, R. F. Smith, and G. N. Pavlakis, 1991. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos. N.M.
31. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
32. Otsyula, M. G., C. J. Miller, M. L. Marthas, K. K. A. Van Rompay, J. R. Collins, N. C. Pedersen, and M. B. McChesney. 1996. Virus-induced immunosuppression is linked to rapidly fatal disease in infant rhesus macaques infected with simian immunodeficiency virus. Pediatr. Res. 39:630-635.
33. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S.-J. Fong, M. Stempein, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:446-454.
34. Perrin, L., A. Rakik, S. Yerly, C. Baumberger, S. Kinloch-de Loes, M. Pechere, and B. Hirschel. 1996. Combined therapy with zidovudine and L-697,661 in primary HIV infection. AIDS 10:1233-1237.
35. Rosenberg, E. S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, and B. D. Walker. 1997. Vigorous HI V-1-specilic CD4+ T cell responses associated with control of viremia. Science 278:1447-1450.
36. Siegrist, C. A., S. Yerly, L. Kaiser, C. A. Wyler, and L. Perrin. 1994. Mother to child transmission of zidovudine-resistant HIV-1. Lancet 344:1771-1772.
37. Sönnerborg, A., B. Johansson, S. Ayehunie, and I. Jolander. 1993. Transmission of zidovudine-resistant HIV-1. AIDS 7:1684-1685.
38. Sperling, R. S., D. E. Shapiro, R. W. Coombs, J. A. Todd, S. A. Herman, G. D. McSherry, M. J. O'Sullivan, R. B. Van Dyke, E. Jiminez, C. Rouzioux, P. M. Flynn, J. L. Sullivan, S. A. Spector, C. Diaz, J. Rooney, J. Balsley, R. D. Gelber, and E. M. Connor. 1996. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N. Engl. J. Med. 335:1621-1629.
39. Tsai, C.-C., P. Emau, K. E. Follis, T. W. Beck, R. E. Benveniste, N. Bischofberger, J. D. Lifson, and W. R. Morton. 1998. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J. Virol. 72:4265-4273.
40. Tsai, C.-C., K. E. Follis, T. W. Beck, A. Sabo, R. F. Grant, N. Bischofberger, and R. E. Benveniste. 1995. Prevention of simian immunodeficiency virus infection in macaques by 9-(2-phosphonylmethoxypropyl)adenine (PMPA). Science 270:1197-1199.
41. Van Rompay, K. K. A., C. J. Berardi, N. L. Aguirre, N. Bischofberger, P. S. Lietman, N. C. Pedersen, and M. L. Marthas. 1998. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS 12:F79-F83.
42. Van Rompay, K. K. A., C. J. Berardi, S. Dillard-Teim, R. P. Tarara, D. R. Canfield, C. R. Valverde, D. C. Montefiori, K. Stefano Cole, R. C. Montelaro, C. J. Miller, and M. L. Marthas. 1998. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J. Infect. Dis. 177:1247-1259.
43. Van Rompay, K. K. A., J. M. Cherrington, M. L. Marthas, C. J. Berardi, A. S. Mulato, A. Spinner, R. P. Tarara, D. R. Canfield, S. Telm, N. Bischofberger, and N. C. Pedersen. 1996. 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob. Agents Chemother. 40:2586-2591.
44. Van Rompay, K. K. A., J. M. Cherrington, M. L. Marthas, P. D. Lamy, P. J. Dailey, D. R. Canfield, R. P. Tarara, N. Bischofberger, and N. C. Pedersen. 1999. 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA. Antimicrob. Agents Chemother. 43: 802-812.
45. Van Rompay, K. K. A., P. J. Dailey, R. P. Tarara, D. R. Canfield, N. L. Aguirre, J. M. Cherrington, P. D. Lamy, N. Bischofberger, N. C. Pedersen, and M. L. Marthas. 1999. Early short-term 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) treatment favorably alters subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques. J. Virol. 73:2947-2955.
46. Van Rompay, K. K. A., J. L. Greenier, M. L. Marthas, M. G. Otsyula, R. P. Tarara, C. J. Miller, and N. C. Pedersen. 1997. A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques. Antimicrob. Agents Chemother. 41:278-283.
47. Van Rompay, K. K. A., M. L. Marthas, J. D. Lifson, C. J. Berardi, G. M. Vasquez, E. Agatep, Z. A. Dehqanzada, K. C. Cundy, N. Bischofberger, and N. C. Pedersen. 1998. Administration of 9-[2-(phosphonomethoxy)propyl] adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res. Hum. Retroviruses 14:761-773.
48. Van Rompay, K. K. A., M. L. Marthas, R. A. Ramos, C. P. Mandell, E. K. McGowan, S. M. Joye, and N. C. Pedersen. 1992. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiret-roviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection. Antimicrob. Agents Chemother. 36:2381-2386.
49. Van Rompay, K. K. A., M. G. Otsyula, M. L. Marthas, C. J. Miller, M. B. McChesney, and N. C. Pedersen. 1995. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob. Agents Chemother. 39:125-131.
50. Van Rompay, K. K. A., M. G. Otsyula, R. P. Tarara, D. R. Canfield, C. J. Berardi, M. B. McChesney, and M. L. Marthas. 1996. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J. Infect. Dis. 173:1327-1335.